All Stories

  1. Hypersensitivity Pneumonitis (Including Environmental Assessment): Diagnosis and Management

    Article • Current Pulmonology Reports, December 2019, Springer Science + Business Media

    Dr Anoop M Nambiar

  2. Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis

    Article • September 2019, European Respiratory Society (ERS)

    Dr Anoop M Nambiar

  3. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

    Article • EBioMedicine, January 2019, Elsevier

    Dr Anoop M Nambiar

  4. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

    Article • European Respiratory Review, December 2018, European Respiratory Society (ERS)

    Dr Anoop M Nambiar

  5. DEBUNKING AND DEBULKING A DIAGNOSIS OF ASTHMA VIA INFLUENZA

    Article • CHEST Journal, October 2018, Elsevier

    Dr Anoop M Nambiar

  6. IF THE STENT FITS, PLACE IT: A NOVEL APPROACH TO THE TREATMENT OF NON-OPERATIVE PULMONARY ARTERY ANGIOSARCOMA

    Article • CHEST Journal, October 2018, Elsevier

    Dr Anoop M Nambiar

  7. TARGETING PRO-INFLAMMATORY CELLS IN IDIOPATHIC PULMONARY FIBROSIS: AN OPEN-LABEL PILOT STUDY OF DASATINIB AND QUERCETIN

    Article • CHEST Journal, October 2018, Elsevier

    Dr Anoop M Nambiar

  8. Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients

    Article • Respiratory Medicine, October 2017, Elsevier

    Dr Anoop M Nambiar

  9. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study

    Article • European Respiratory Journal, August 2017, European Respiratory Society (ERS)

    Dr Anoop M Nambiar, Dr Giovanni Ferrara, Dr Michael Perch, Satoshi Ikeda, Dr Tiago M Alfaro, MD Pilar Rivera Ortega

  10. Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis

    Article • PLoS ONE, April 2017, PLOS

    Dr Anoop M Nambiar

  11. Acute Lower Gastrointestinal Bleeding

    Article • January 2017, Springer Science + Business Media

    Dr Anoop M Nambiar

  12. Diagnosis and Management of Thrombotic Thrombocytopenic Purpura

    Article • January 2017, Springer Science + Business Media

    Dr Anoop M Nambiar

  13. Clogging the Pipes

    Article • CHEST Journal, October 2016, Elsevier

    Dr Anoop M Nambiar

  14. P032 Effectiveness and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis

    Article • QJM, September 2016, Oxford University Press (OUP)

    Dr Anoop M Nambiar

  15. Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: Does it take these two to tango?

    Article • Respirology, February 2015, Wiley

    Dr Anoop M Nambiar

  16. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

    Article • New England Journal of Medicine, May 2014, New England Journal of Medicine (NEJM/MMS)

    Dr Anoop M Nambiar, David Lederer, Prof Dr Carlos R R Carvalho

  17. Procalcitonin in acute exacerbations of interstitial pneumonia: Another tool in the toolbox?

    Article • Respirology, March 2013, Wiley

    Dr Anoop M Nambiar

  18. Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

    Article • Infection and Drug Resistance, February 2012, Taylor & Francis

    Dr Anoop M Nambiar, Dr Marcos I. Restrepo

  19. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema

    Article • European Respiratory Journal, December 2010, European Respiratory Society (ERS)

    Dr Anoop M Nambiar

  20. Longitudinal Changes In The Composite Physiologic Index And Pulmonary Function In Patients With Idiopathic Pulmonary Fibrosis And Emphysema

    Article • May 2010, American Thoracic Society

    Dr Anoop M Nambiar